Bio-Path Holdings (BPTH) Tops Q3 EPS by 2c

Bio-Path Holdings (NASDAQ: BPTH) reported Q3 EPS of ($0.32), $0.02 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Worthington Industries (WOR) Misses Q4 EPS by 9c
• Ennis (EBF) Reports In-Line Q1 EPS